Schriftgut
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 3
Enthält:
Pharmakologische und toxikologische Studien des Zulassungsantrags;
Literatur zu Azathioprin
- Reference number
-
Bundesarchiv, BArch DQ 116/4389
- Language of the material
-
deutsch
- Context
-
Institut für Arzneimittelwesen (IFAR) der DDR >> DQ 116 Institut für Arzneimittelwesen (IFAR) der DDR >> Zulassung von im Ausland hergestellten Arzneimitteln in der DDR (Importe) >> Großbritannien (00/09) >> Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited)
- Holding
-
BArch DQ 116 Institut für Arzneimittelwesen (IFAR) der DDR
- Provenance
-
Institut für Arzneimittelwesen der DDR (IFAR), 1974-1990
- Date of creation
-
1963-1983
- Other object pages
- Last update
-
30.01.2024, 2:28 PM CET
Data provider
This object is provided by:
Bundesarchiv. If you have any questions about the object, please contact the data provider.
Bundesarchiv. If you have any questions about the object, please contact the data provider.
Object type
- Schriftgut
Associated
- Institut für Arzneimittelwesen der DDR (IFAR), 1974-1990
Time of origin
- 1963-1983
Other Objects (12)
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 4
Trexan (Farmos Group Limited): Ampullen 500 mg
Trexan (Farmos Group Limited): Ampullen 50 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten, 40 mg/ml Depotinjektion-Ampullen und 125 mg Ampullen
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen 250 mg intravenös
Azathioprin-Tabletten 50 mg (Medexport)
Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg
Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 40 mg/ml Depotinjektion-Ampullen
Rubomycin-Ampullen 20 mg
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 4
Trexan (Farmos Group Limited): Ampullen 500 mg
Trexan (Farmos Group Limited): Ampullen 50 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten, 40 mg/ml Depotinjektion-Ampullen und 125 mg Ampullen
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen 250 mg intravenös
Azathioprin-Tabletten 50 mg (Medexport)
Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg
Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 40 mg/ml Depotinjektion-Ampullen
Rubomycin-Ampullen 20 mg
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 1
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 2
Imuran/Azathioprin-Ampullen 50 mg (The Wellcome Foundation Limited): Bd. 4
Trexan (Farmos Group Limited): Ampullen 500 mg
Trexan (Farmos Group Limited): Ampullen 50 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 4 mg Tabletten, 40 mg/ml Depotinjektion-Ampullen und 125 mg Ampullen
Metypred (Orion Corporation Limited/Orion Pharmaceutica): Ampullen 250 mg intravenös
Azathioprin-Tabletten 50 mg (Medexport)
Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 100 mg
Retrovir/Zidovudin (The Wellcome Foundation Limited): Kapseln 250 mg
Metypred (Orion Corporation Limited/Orion Pharmaceutica): 40 mg/ml Depotinjektion-Ampullen